Sinovac Biotech, Ltd. Ordinary Shares (NASDAQ: SVA) last traded at $6.47, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from Sinovac Biotech, Ltd. Ordinary Shares’s own filings and are restated only when a new one is published.
Sinovac Biotech, Ltd. Ordinary Shares trades on NASDAQ under the ticker SVA. Its market capitalisation is $464.94 million.
Valuation measures for Sinovac Biotech, Ltd. Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $464.94M |
|---|---|
| Enterprise value | $2.12B |
| Price / sales | 1.20 |
| Price / book | 0.10 |
Trailing-twelve-month figures tagged in Sinovac Biotech, Ltd. Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $386.01M |
|---|---|
| Net income (TTM) | -$198.84M |
| Gross margin | 67.87% |
| Operating margin | -126.97% |
| Return on equity | -4.48% |
| Cash | $488.25M |
Range and volume for SVA over the past 52 weeks.
| 52-week high | $6.47 |
|---|---|
| 52-week low | $6.47 |
| Volume | 0 |
| Previous close | $6.47 |
Dividend history for Sinovac Biotech, Ltd. Ordinary Shares over the trailing twelve months.
| Dividend yield | 850.08% |
|---|---|
| Dividend per share (TTM) | $55.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.